The risk of bacterial endocarditis during antirheumatic prophylaxis.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002648:Child; D004697:Endocarditis, Bacterial / Q000150:complications / Q000209:etiology*; D005260:Female; D006801:Humans; D007592:Joint Diseases; D009461:Neurologic Manifestations; D010400:Penicillin G / Q000009:adverse effects / Q000627:therapeutic use; D010401:Penicillin G Benzathine / Q000009:adverse effects / Q000627:therapeutic use; D010403:Penicillin Resistance; D012214:Rheumatic Heart Disease / Q000517:prevention & control*; D012877:Skin Manifestations; D013411:Sulfadiazine / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D010400:Penicillin G; D010401:Penicillin G Benzathine